Neil Osheroff

Through his work, Neil Osheroff reaches medical students at Vanderbilt and around the globe with his innovative ideas. Read More

The Lillian B. Nanney Award for Outstanding Service to the VUSM/VUMC Community of Educators is a lifetime achievement award established to recognize an Academy for Excellence in Education faculty member who has demonstrated sustained outstanding service to the Vanderbilt community of educators. This year’s winner is Neil Osheroff, John G. Coniglio Professor of Biochemistry and professor of Medicine. Read More

Led by Neil Osheroff, Vanderbilt researchers are the first to undertake a systematic analysis of the mechanism of action of geoptidacin. Gepotidacin is poised to become the first new class of antibacterials to be approved for use in humans in decades. Read More

Neil Osheroff, professor of biochemistry and medicine, is part of an international research collaboration resulting in what is on track to be the first new antibiotic treatment for uncomplicated urinary tract infections or uUTIs in more than 20 years. Read More

As a professor of biochemistry and medicine at Vanderbilt University School of Medicine for more than 40 years, Osheroff is the longest serving course director currently teaching medical students. He also codirects the preclerkship phase of the medical school curriculum and leads the Master Science Teachers cohort, a role established in 2007 to recognize VUSM’s outstanding basic science educators. Through his teaching, he has helped medical students at VUSM and across the globe acquire the basic science skills and knowledge they need to thrive in clinical practice, according to the AAMC. Read More

Neil Osheroff, John G. Coniglio Chair in Biochemistry and professor of biochemistry and medicine, received the Mentoring, Innovation, and Leadership in Educational Scholarship Award at the annual Asia Pacific Medical Education Conference that took place in May. Read More

Neil Osheroff, John Coniglio Chair in Biochemistry and professor of biochemistry and medicine, is part of an international research collaboration resulting in what is on track to be the first new antibiotic treatment for uncomplicated urinary tract infections in more than 20 years. “We now have a direct path connecting… Read More